These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19542076)

  • 1. Hazard ratio funnel plots for survival comparisons.
    Silcocks P
    J Epidemiol Community Health; 2009 Oct; 63(10):856-61. PubMed ID: 19542076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Funnel plots for comparing performance of PCI performing hospitals and cardiologists: demonstration of utility using the New York hospital mortality data.
    Kunadian B; Dunning J; Roberts AP; Morley R; de Belder MA
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):589-94. PubMed ID: 19309714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating survival model performance: a graphical approach.
    Mandel M; Galai N; Simchen E
    Stat Med; 2005 Jun; 24(12):1933-45. PubMed ID: 15806618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced-rank hazard regression for modelling non-proportional hazards.
    Perperoglou A; le Cessie S; van Houwelingen HC
    Stat Med; 2006 Aug; 25(16):2831-45. PubMed ID: 16158396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ErbB-3 predicts survival in ovarian cancer.
    Tanner B; Hasenclever D; Stern K; Schormann W; Bezler M; Hermes M; Brulport M; Bauer A; Schiffer IB; Gebhard S; Schmidt M; Steiner E; Sehouli J; Edelmann J; Läuter J; Lessig R; Krishnamurthi K; Ullrich A; Hengstler JG
    J Clin Oncol; 2006 Sep; 24(26):4317-23. PubMed ID: 16896008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piecewise exponential survival trees with time-dependent covariates.
    Huang X; Chen S; Soong SJ
    Biometrics; 1998 Dec; 54(4):1420-33. PubMed ID: 9883542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The estimation of average hazard ratios by weighted Cox regression.
    Schemper M; Wakounig S; Heinze G
    Stat Med; 2009 Aug; 28(19):2473-89. PubMed ID: 19472308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjusted survival curves with inverse probability weights.
    Cole SR; Hernán MA
    Comput Methods Programs Biomed; 2004 Jul; 75(1):45-9. PubMed ID: 15158046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the role of risk-adjusted funnel plots in the analysis of radical cystectomy volume-outcome relationships?
    Mayer EK; Bottle A; Aylin P; Darzi AW; Vale JA; Athanasiou T
    BJU Int; 2011 Sep; 108(6):844-50. PubMed ID: 21884357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Funnel plots and their emerging application in surgery.
    Mayer EK; Bottle A; Rao C; Darzi AW; Athanasiou T
    Ann Surg; 2009 Mar; 249(3):376-83. PubMed ID: 19247021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualizing covariates in proportional hazards model.
    Karvanen J; Harrell FE
    Stat Med; 2009 Jun; 28(14):1957-66. PubMed ID: 19378282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On robustness and model flexibility in survival analysis: transformed hazard models and average effects.
    Gustafson P
    Biometrics; 2007 Mar; 63(1):69-77. PubMed ID: 17447931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some diagnostic methods for Cox regression models through hazard smoothing.
    Gray RJ
    Biometrics; 1990 Mar; 46(1):93-102. PubMed ID: 2190638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival analytical techniques were used to assess agreement of a quantitative variable.
    Llorca J; Delgado-Rodríguez M
    J Clin Epidemiol; 2005 Mar; 58(3):314-5. PubMed ID: 15718122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reformulating the hazard ratio to enhance communication with clinical investigators.
    Moser BK; McCann MH
    Clin Trials; 2008; 5(3):248-52. PubMed ID: 18559414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Providing more up-to-date estimates of patient survival: a comparison of standard survival analysis with period analysis using life-table methods and proportional hazards models.
    Smith LK; Lambert PC; Botha JL; Jones DR
    J Clin Epidemiol; 2004 Jan; 57(1):14-20. PubMed ID: 15019006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An approach to estimation in relative survival regression.
    Perme MP; Henderson R; Stare J
    Biostatistics; 2009 Jan; 10(1):136-46. PubMed ID: 18599516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens.
    Caubet JF; Tosteson TD; Dong EW; Naylon EM; Whiting GW; Ernstoff MS; Ross SD
    Urology; 1997 Jan; 49(1):71-8. PubMed ID: 9000189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative incidence in competing risks data and competing risks regression analysis.
    Kim HT
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.